Daily News Podcast

Novel formulation for childhood ADHD

Publish date: November 20, 2018

 

A novel formulation of methylphenidate could provide morning relief to pediatric patients with attention-deficit hyperactivity disorder. Also today, CARE MD protocol could help treat somatic disorders, children with poor cardiorespiratory fitness have a higher risk of type 2 diabetes, and ganglion stimulation boosts cerebral blood flow and improves stroke outcomes.
Amazon Alexa
Apple Podcasts
Google Podcasts

Recommended Reading

Samuel Shem: Part II
MDedge Pediatrics
Nearly half of infants don’t sleep through the night at 1 year
MDedge Pediatrics
Trump rule and ACA contraception
MDedge Pediatrics
How, and when, to use fat grafting for scars
MDedge Pediatrics
DBT can help traumatized, suicidal youth manage emotions
MDedge Pediatrics
Heart failure and sacubiril/valsartan
MDedge Pediatrics
Vitamin D, fish out, and primary prevention
MDedge Pediatrics
USPSTF: screen for ‘unhealthy’ alcohol use
MDedge Pediatrics
Obesity curbs decades of CVD progress
MDedge Pediatrics
Physical fitness guidelines from HHS
MDedge Pediatrics